Sign up now to have the right to view
50 tenders for free.
Contract Details
| Title |
Discounting Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Imatinib - Patent-free Indications - As Part of a So-called Open-house Model. Germany |
|||
|---|---|---|---|---|
You can sign up and unlock it for freeAccess to Public and Private Sector Business Opportunities for 200+ Countries |
||||
| Country | ||||
| Language | English | |||
| Organization | ||||
| Published Date | 06.02.2024 | |||
| Awarded Date | 18.03.2021 | |||
| Overview | Contract Award's Details : Discounting Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Imatinib - Patent-free Indications - As Part of a So-called Open-house Model. AOK - RHINELAND-PALATINATE / SAARLAND - THE HEALTH INSURANCE Discounting Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Imatinib - Patent-free Indications - As Part of a So-called Open-house Model. Document Type: Contract Award Notice Title: Discount not exclusive discount contracts pursuant to Section 130a (8) SGB V for medicaments with the active ingredient Imatinib - Patent-free indications - as part of a so-called open-house model. Reference Number: 2021 / S 050-124054 Contract Type: Supplies Estimated Value: 0.01 - EUR DESCRIPTION: Discounting non-exclusive discount contracts pursuant to Section 130a (8) SGB V for medicaments with the active ingredient active substance Imatinib (ATC code: L01XE01) - Patent-free indications - within the period of 1.3.2021 to 28.2.2023 with any possibility of the conclusion of the contract ( Open-House model). 33600000 - Pharmaceutical Products Authority Type: Body Governed by Public Law Type of Procedure: Open Procedure Regulation: European Union Bid Type: Not Applicable Doc Title: Pharmaceutical Products Dispatch Date: 2021-03-09 Publish Date: 2021-03-12 Germany Contract value : 0.01 EUR Contractors : ZENTIVA PHARMA GMBH, PUREN PHARMA GMBH & CO. KG, BETAPHARM ARZNEIMITTEL GMBH, ONKOVIS GMBH, HEUMANN PHARMA GMBH & CO GENERIKA KG, DEVATIS GMBH, DENK PHARMA GMBH & CO. KG 05/02/2021 19/03/2021 See in details 77158875 19/03/2021 AOK - RHINELAND-PALATINATE / SAARLAND - THE HEALTH INSURANCE Address : Address : Virchowstra e 30 Town : Eisenberg NUTS-Code : DE - Deutschland Postal Code : 67304 Contact Point : Jennifer Rheinfrank Phone : +49 6351403203 www.aok.de/rheinland-pfalz-saarland/ am_vertraege@rps.aok.de Germany Germany Contract Awards Germany 05/02/2021 See in details 0.01 EUR | |||
| NAICS | ||||
| CPVS | ||||
| UNSPSC |
-
|
|||
| Regions | ||||
| Sectors | ||||
| Contractor | ||||
| Contract Value |
0.01 EUR
|
URL | ||
| Share | ||||
Germany
| Title |
|---|
Discounting Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Imatinib - Patent-free Indications - As Part of a So-called Open-house Model. Germany |
| Country |
| Language |
| English |
| Organization |
| Published Date |
| 06.02.2024 |
| Awarded Date |
| 18.03.2021 |
| Overview |
| Contract Award's Details : Discounting Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Imatinib - Patent-free Indications - As Part of a So-called Open-house Model. AOK - RHINELAND-PALATINATE / SAARLAND - THE HEALTH INSURANCE Discounting Non-exclusive Discount Contracts Pursuant to Section 130a (8) Sgb V for Medicaments with the Active Substance Imatinib - Patent-free Indications - As Part of a So-called Open-house Model. Document Type: Contract Award Notice Title: Discount not exclusive discount contracts pursuant to Section 130a (8) SGB V for medicaments with the active ingredient Imatinib - Patent-free indications - as part of a so-called open-house model. Reference Number: 2021 / S 050-124054 Contract Type: Supplies Estimated Value: 0.01 - EUR DESCRIPTION: Discounting non-exclusive discount contracts pursuant to Section 130a (8) SGB V for medicaments with the active ingredient active substance Imatinib (ATC code: L01XE01) - Patent-free indications - within the period of 1.3.2021 to 28.2.2023 with any possibility of the conclusion of the contract ( Open-House model). 33600000 - Pharmaceutical Products Authority Type: Body Governed by Public Law Type of Procedure: Open Procedure Regulation: European Union Bid Type: Not Applicable Doc Title: Pharmaceutical Products Dispatch Date: 2021-03-09 Publish Date: 2021-03-12 Germany Contract value : 0.01 EUR Contractors : ZENTIVA PHARMA GMBH, PUREN PHARMA GMBH & CO. KG, BETAPHARM ARZNEIMITTEL GMBH, ONKOVIS GMBH, HEUMANN PHARMA GMBH & CO GENERIKA KG, DEVATIS GMBH, DENK PHARMA GMBH & CO. KG 05/02/2021 19/03/2021 See in details 77158875 19/03/2021 AOK - RHINELAND-PALATINATE / SAARLAND - THE HEALTH INSURANCE Address : Address : Virchowstra e 30 Town : Eisenberg NUTS-Code : DE - Deutschland Postal Code : 67304 Contact Point : Jennifer Rheinfrank Phone : +49 6351403203 www.aok.de/rheinland-pfalz-saarland/ am_vertraege@rps.aok.de Germany Germany Contract Awards Germany 05/02/2021 See in details 0.01 EUR |
| NAICS |
| Other Direct Insurance (except Life Justice Regulation Justice Other Justice Regulation Direct Insurance (except Life Direct Life Other Justice |
| CPVS |
| Sections Postal orders Dates |
| UNSPSC |
| - |
| Regions |
| Europe Western Europe |
| Sectors |
| Healthcare and Medicine Automobiles and Auto Parts Supply Postal and Courier Services Law and Legal Printing and Publishing Electricity Construction Energy-Power and Electrical Computer Hardwares and Consumables Steel Pharmaceuticals |
| Contractor |
| Contract Value |
|
0.01 EUR
|
| URL |
|
|
| Share |
To be notified
when a tender matching your filter is
published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
Similar Contracts